04:36 PM EDT, 06/18/2024 (MT Newswires) -- Akili ( AKLI ) said Tuesday its video game app, EndeavorOTC, has received a clearance from the US Food and Drug Administration as an over-the-counter treatment for adults with attention-deficit/hyperactivity disorder.

The company said EndeavorOTC is its second digital ADHD therapeutic to receive FDA authorization. EndeavorOTC is available in the US on the Apple App Store for iOS and the Google Play Store for Android mobile devices.